CASI PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
CASI PHARMACEUTICALS, INC. (CASIF) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$247.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-05-15
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2024-12-31 | -$247.00K 20-F · filed 2026-05-15 |
| 2023-12-31 | -$314.00K 20-F · filed 2026-05-15 |
| 2022-12-31 | -$138.00K 20-F · filed 2025-03-31 |
| 2021-12-31 | $9.00K 20-F · filed 2024-03-28 |
| 2020-12-31 | -$54.00K 20-F · filed 2023-04-26 |